Spinraza is a brand that offers products and services for individuals affected by Spinal Muscular Atrophy (SMA), a genetic disorder that affects the central nervous system and all the muscles in the body. SMA is caused by a lack of survival motor neuron (SMN) protein, which is essential for muscle development and movement. Spinraza provides a prescription medicine, also called Spinraza, that is used to treat SMA in pediatric and adult patients.

The medicine helps to increase the production of SMN protein and slow down the progression of the disease. Before starting treatment with Spinraza, it is important to consult with a healthcare provider and undergo genetic testing to confirm an SMA diagnosis. Spinraza prioritizes safety and provides important safety information and prescribing information for healthcare professionals and patients.

Stay connected with Spinraza to receive the latest news, support information, and upcoming events